Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-20-052339

Director bought 950,000 shares at $18.00 ($17,100,000)

  • Director acquired 6,114,330 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

ORBIMED ADVISORS LLC · Director

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-25 Purchase : show line 1 in the form +475,000 $18.00 $8,550,000 475,000 I
2020-09-29 Conversion : show line 2 in the form +4,025,076 4,500,076 I
2020-09-29 Conversion : show line 3 in the form +1,076,891 5,576,967 I
2020-09-29 Conversion : show line 4 in the form +518,191 6,095,158 I
2020-09-29 Conversion : show line 5 in the form +380,133 6,475,291 I
2020-09-29 Conversion : show line 6 in the form +114,039 114,039 I
2020-09-25 Purchase : show line 7 in the form +475,000 $18.00 $8,550,000 475,000 I
Open-market purchases · 950,000 sh · avg $18.00 · $17,100,000

Table II: Derivative

5 lines
Date Transaction Shares Owned after D/I
2020-09-29 Conversion : show line 8 in the form Series A Preferred Stock −4,025,076 0 I
2020-09-29 Conversion : show line 9 in the form Series B Preferred Stock −1,076,891 0 I
2020-09-29 Conversion : show line 10 in the form Series C Preferred Stock −518,191 0 I
2020-09-29 Conversion : show line 11 in the form Series D Preferred Stock −380,133 0 I
2020-09-29 Conversion : show line 12 in the form Series D Preferred Stock −114,039 0 I
Loading xslF345X03/doc4.xml…